CR

CRISM Therapeutics Corporation

Develops drug delivery technology for localized chemotherapy in solid tumors.

CRTX | US

Overview

Corporate Details

ISIN(s):
VGG042401262
LEI:
213800XFW6MKVCHHPW88
Country:
Virgin Islands (British)
Address:
C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN

Description

CRISM Therapeutics Corporation is a pharmaceutical company focused on developing advanced drug delivery technologies. Its flagship product, ChemoSeed®, is an implantable, biodegradable technology designed for the sustained and localized delivery of chemotherapy drugs directly into solid tumors. The primary objective of this approach is to enhance the efficacy of cancer treatments by concentrating therapeutic agents at the tumor site, thereby minimizing systemic toxicity and associated side effects. The company's technology aims to improve the clinical performance of cancer therapies and the bioavailability of poorly soluble compounds, with a mission to provide more effective and better-tolerated treatments to improve patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-10-14 10:26
Director Change
English 10.8 KB
2020-10-12 17:36
Price Monitoring Extension
English 3.0 KB
2020-10-07 08:00
NRR Update
English 10.2 KB
2020-09-30 08:00
Interim Results 2020
English 194.4 KB
2020-09-03 08:00
Exercise of Warrants and Issue of Equity
English 9.9 KB
2020-09-02 08:00
Executive Addition to the Board of Directors
English 18.6 KB
2020-08-25 09:50
Equity Placing to raise £6.1 million
English 48.3 KB
2020-08-19 17:40
Second Price Monitoring Extn
English 2.4 KB
2020-08-19 17:35
Price Monitoring Extension
English 2.4 KB
2020-08-07 17:41
Second Price Monitoring Extn
English 2.4 KB
2020-08-07 17:35
Price Monitoring Extension
English 2.4 KB
2020-08-04 17:37
Exercise of Warrants and Issue of Equity
English 9.4 KB
2020-07-21 17:41
Second Price Monitoring Extn
English 2.4 KB
2020-07-21 17:36
Price Monitoring Extension
English 2.4 KB
2020-07-15 17:39
Exercise of Warrants and Issue of Equity
English 9.3 KB

Automate Your Workflow. Get a real-time feed of all CRISM Therapeutics Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRISM Therapeutics Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CRISM Therapeutics Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.